Network Pharmacology–Based Identification of Key Mechanisms of Xihuang Pill in the Treatment of Triple-Negative Breast Cancer Stem Cells

Xihuang pill, an approved Chinese medicine formula (state medical permit number. Z11020073), is a commonly used adjuvant drug for cancer patients in China. Xihuang pill has a satisfactory effect in treating breast cancer in clinics, especially triple-negative breast cancer (TNBC), which is the most...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu-Zhu, Yang, Jia-Yao, Wu, Rui-Xian, Fang, Chen, Lu, Hai, Li, Hua-Chao, Li, Dong-Mei, Zuo, Hua-Li, Ren, Li-Ping, Liu, Xiao-Yuan, Xu, Rui, Wen, Jia-Huai, Huang, Hsien-Da, Hong, Ri, Chen, Qian-Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560791/
https://www.ncbi.nlm.nih.gov/pubmed/34737698
http://dx.doi.org/10.3389/fphar.2021.714628

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560791/
https://www.ncbi.nlm.nih.gov/pubmed/34737698
http://dx.doi.org/10.3389/fphar.2021.714628

Ejemplares similares